SRTS
Sensus Healthcare Inc

1,182
Mkt Cap
$73.6M
Volume
93,909.00
52W High
$9.33
52W Low
$3.03
PE Ratio
-23.39
SRTS Fundamentals
Price
$4.32
Prev Close
$4.46
Open
$4.41
50D MA
$3.39
Beta
0.95
Avg. Volume
77,955.57
EPS (Annual)
$0.4063
P/B
1.39
Rev/Employee
$774,203.70
Loading...
Loading...
News
all
press releases
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·19h ago
News Placeholder
More News
News Placeholder
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·3d ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Sensus Healthcare from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·7d ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Releases Earnings Results, Beats Estimates By $0.06 EPS
Sensus Healthcare (NASDAQ:SRTS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.12...
MarketBeat·7d ago
News Placeholder
Sensus Healthcare, Inc. (SRTS) Reports Q3 Loss, Tops Revenue Estimates
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of +50.00% and +48.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
Sensus Healthcare Reports Third Quarter 2025 Financial Results
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·8d ago
News Placeholder
Sensus Healthcare Named to TIMEs Americas Growth Leaders of 2026
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·9d ago
News Placeholder
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·11d ago
News Placeholder
Sensus Healthcare Announces the Passing of Director Bill McCall
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·15d ago
News Placeholder
Sensus Healthcare, Inc. (SRTS) Stock Moves -1.83%: What You Should Know
Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $3.21, signifying a -1.83% move from its prior day's close.
Zacks·16d ago

Latest SRTS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.